(Q30429289)

21 June 2017

title

Adjunctive therapies and immunomodulatory agents in the management of severe influenza (English)

1 reference

21 June 2017

Nelson Lee

2

0 references

David Shu-cheong Hui

object named as

David S Hui

series ordinal

1

0 references

Paul Kay-Sheung Chan

object named as

Paul K Chan

series ordinal

3

0 references

publication date

8 April 2013

1 reference

21 June 2017

1 reference

21 June 2017

volume

98

1 reference

21 June 2017

issue

3

1 reference

21 June 2017

page(s)

410-416

1 reference

Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients

21 June 2017

cites work

1 reference

12 December 2020

Clarithromycin inhibits type a seasonal influenza virus infection in human airway epithelial cells

1 reference

12 December 2020

Clarithromycin inhibits progeny virus production from human influenza virus-infected host cells.

1 reference

12 December 2020

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice

1 reference

12 December 2020

Re-emergence of fatal human influenza A subtype H5N1 disease

1 reference

12 December 2020

Role of oxidants in influenza virus-induced gene expression.

1 reference

12 December 2020

Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS).

1 reference

12 December 2020

Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis

1 reference

12 December 2020

Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010.

1 reference

12 December 2020

Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice.

1 reference

12 December 2020

Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome

1 reference

12 December 2020

Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

1 reference

12 December 2020

Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.

1 reference

12 December 2020

Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial

1 reference

12 December 2020

Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice

1 reference

12 December 2020

Large artery ischaemic stroke in severe acute respiratory syndrome (SARS).

1 reference

12 December 2020

TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.

1 reference

12 December 2020

Azithromycin induces anti-viral responses in bronchial epithelial cells

1 reference

12 December 2020

Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection

1 reference

12 December 2020

Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores

1 reference

12 December 2020

Fatal aspergillosis in a patient with SARS who was treated with corticosteroids

1 reference

12 December 2020

Cross-reactive neutralizing antibody against pandemic 2009 H1N1 influenza a virus in intravenous immunoglobulin preparations

1 reference

12 December 2020

Hypercytokinemia with 2009 pandemic H1N1 (pH1N1) influenza successfully treated with polymyxin B-immobilized fiber column hemoperfusion

1 reference

12 December 2020

Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease

1 reference

12 December 2020

A major outbreak of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study

1 reference

12 December 2020

The effect of rosuvastatin in a murine model of influenza A infection

1 reference

12 December 2020

Clarithromycin has limited effects in non-elderly, non-severe patients with seasonal influenza virus A infection

1 reference

12 December 2020

Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry.

1 reference

12 December 2020

Clinical management of pandemic 2009 influenza A(H1N1) infection.

1 reference

12 December 2020

Influenza morbidity and mortality in elderly patients receiving statins: a cohort study.

1 reference

12 December 2020

Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan

1 reference

12 December 2020

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

1 reference

12 December 2020

Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.

1 reference

12 December 2020

Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection

1 reference

12 December 2020

Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection

1 reference

12 December 2020

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

1 reference

12 December 2020

Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids

1 reference

12 December 2020

A case of acute respiratory distress syndrome associated with novel H1N1 treated with intravenous immunoglobulin G.

1 reference

12 December 2020

Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

1 reference

12 December 2020

N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus.

1 reference

12 December 2020

Invasive aspergillosis after pandemic (H1N1) 2009.

1 reference

12 December 2020

Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome.

1 reference

12 December 2020

Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.

1 reference

12 December 2020

Antioxidants, cytokines, and influenza infection in aged mice and elderly humans

1 reference

12 December 2020

Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection.

1 reference

12 December 2020

Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work.

1 reference

12 December 2020

Outcomes of adults hospitalised with severe influenza.

1 reference

12 December 2020

Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection

1 reference

12 December 2020

Increased survival after gemfibrozil treatment of severe mouse influenza

1 reference

12 December 2020

Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza?

1 reference

12 December 2020

Dexamethasone in community-acquired pneumonia

1 reference

12 December 2020

Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis

1 reference

12 December 2020

Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997.

1 reference

12 December 2020

Treatment with convalescent plasma for influenza A (H5N1) infection

1 reference

12 December 2020

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

1 reference

12 December 2020

Avascular necrosis of bone in severe acute respiratory syndrome

1 reference

12 December 2020

Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.

1 reference

12 December 2020

Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome

1 reference

12 December 2020

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.

1 reference

12 December 2020

Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia.

1 reference

12 December 2020

Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A--an associated respiratory failure and hemodynamic shock.

1 reference

12 December 2020

High-dose N-acetylcysteine therapy for novel H1N1 influenza pneumonia

1 reference

12 December 2020

Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis

1 reference

12 December 2020

10.1016/J.ANTIVIRAL.2013.03.019

Identifiers

DOI

1 reference

21 June 2017

0 references

1 reference